Belladonna and Dilaudid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Belladonna (belladonna) and Dilaudid (hydromorphone hydrochloride). Common drug interactions include asthma among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Belladonna and Dilaudid. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Belladonna?

Belladonna has active ingredients of belladonna. It is often used in irritable bowel syndrome. eHealthMe is studying from 1,043 Belladonna users. Check the latest studies of Belladonna.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.



On Jul, 13, 2026

11 people who take Belladonna and Dilaudid together, and have interactions are studied.

Belladonna and Dilaudid drug interactions.

What are the common drug interactions of Belladonna and Dilaudid, by gender? *:

female:

  1. Asthma
  2. Blood calcium decreased
  3. Chest pain
  4. Chronic kidney disease
  5. Constipation
  6. Cough
  7. Death
  8. Drug hypersensitivity
  9. Dyspnoea (difficult or laboured respiration)
  10. Epstein-barr virus infection

male:

  1. Anaemia (lack of blood)
  2. Carotid artery stenosis (narrowing of carotid artery)
  3. Dyspnoea (difficult or laboured respiration)
  4. Ileus (a painful obstruction of the ileum or other part of the intestine)
  5. Overdose
  6. Suicidal ideation
  7. Cerebral artery stenosis (hardening of brain blood vessels)
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Transient global amnesia (a temporary short-term memory loss)
  10. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

What are the common drug interactions of Belladonna and Dilaudid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Cholecystitis chronic (long lasting infection of gallbladder)
  3. Food intolerance (inability to have food)
  4. Gallbladder disorder
  5. Nausea (feeling of having an urge to vomit)
  6. Vomiting

40-49:

  1. Breast mass
  2. Mass
  3. Neck mass (mass in neck)

50-59:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

60+:

  1. Anaemia (lack of blood)
  2. Carotid artery stenosis (narrowing of carotid artery)
  3. Drug dependence
  4. Dyspnoea (difficult or laboured respiration)
  5. Ileus (a painful obstruction of the ileum or other part of the intestine)
  6. Overdose
  7. Suicidal ideation
  8. Cerebral artery stenosis (hardening of brain blood vessels)
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Transient global amnesia (a temporary short-term memory loss)

What are the existing conditions these people have? *

  1. Depression: 4 people, 36.36%
  2. Neck Pain: 3 people, 27.27%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 27.27%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 18.18%
  5. Infection: 2 people, 18.18%
  6. Blood Pressure Abnormal: 2 people, 18.18%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 18.18%
  8. Constipation: 2 people, 18.18%
  9. Diabetes: 2 people, 18.18%
  10. Fluid Imbalance (imbalance of fluid in body in intake and fluid lost): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Belladonna and Dilaudid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Belladonna and Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Belladonna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dilaudid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Belladonna and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dilaudid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on belladonna and hydromorphone hydrochloride (the active ingredients of Belladonna and Dilaudid, respectively), and Belladonna and Dilaudid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: